Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy - PubMed (original) (raw)

Clinical Trial

Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy

Fulvio Bertolotto et al. Drugs R D. 2012.

Abstract

Background and objective: The management of diabetic neuropathy is still a challenge for physicians. The aim of this study was to assess the efficacy of a new combination of alpha lipoic acid and superoxide dismutase for the treatment of diabetic neuropathy.

Methods: The setting of this study was ambulatory (outpatient) care. A prospective, non-randomized, open-label study was conducted in 50 patients with diabetes mellitus and with a deficit in both motor and sensory nerve conduction. Treatment was with a new combination of alpha lipoic acid and superoxide dismutase (ALA600SOD®) for 4 months. Electroneurographic parameters and perceived pain were assessed at baseline and after treatment.

Results: After 4 months of treatment, patients significantly (p < 0.001) improved their electroneurographic parameters and their perception of pain. Best improvements were observed in sensory nerve conduction.

Conclusion: The combination of two powerful antioxidant agents leads to improvement in both subjective and objective parameters in patients with diabetic neuropathy. New profitable directions for investigations are opened for a non-invasive treatment of diabetic neuropathy in the future.

PubMed Disclaimer

Figures

Table I

Parameters pre- and post-treatment with variation in the whole samplea

Fig. 1

The percentages of patients that improved, remained stable or worsened in the measured parameters after treatment. MNCMNC= motor nerve conduction; SNC = sensory nerve conduction; VAS = visual analog scale.

Cited by

Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.
Serhiyenko VA, Serhiyenko AA. Serhiyenko VA, et al. World J Diabetes. 2018 Jan 15;9(1):1-24. doi: 10.4239/wjd.v9.i1.1. World J Diabetes. 2018. PMID: 29359025 Free PMC article. Review.
Neurons and Microglia; A Sickly-Sweet Duo in Diabetic Pain Neuropathy.
Rajchgot T, Thomas SC, Wang JC, Ahmadi M, Balood M, Crosson T, Dias JP, Couture R, Claing A, Talbot S. Rajchgot T, et al. Front Neurosci. 2019 Jan 31;13:25. doi: 10.3389/fnins.2019.00025. eCollection 2019. Front Neurosci. 2019. PMID: 30766472 Free PMC article. Review.
Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.
Didangelos T, Karlafti E, Kotzakioulafi E, Kontoninas Z, Margaritidis C, Giannoulaki P, Kantartzis K. Didangelos T, et al. Nutrients. 2020 Oct 23;12(11):3254. doi: 10.3390/nu12113254. Nutrients. 2020. PMID: 33114210 Free PMC article. Clinical Trial.
Strategies and Research Progress of Chinese Medicine in Prevention and Treatment of Diabetic Peripheral Neuropathy.
Yang D, Liang XC. Yang D, et al. Chin J Integr Med. 2018 Oct;24(10):794-800. doi: 10.1007/s11655-018-3051-x. Epub 2018 Sep 29. Chin J Integr Med. 2018. PMID: 30267371 Review.
Lipoic Acid Exerts Antioxidant and Anti-inflammatory Effects in Response to Heat Shock in C2C12 Myotubes.
Lee CT, Chang LC, Wu PF. Lee CT, et al. Inflammation. 2016 Jun;39(3):1160-8. doi: 10.1007/s10753-016-0350-2. Inflammation. 2016. PMID: 27086282

References

1. Mijnhout GS, Alkhalaf A, Kleefstra N, et al. Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes. Neth J Med. 2010;68(4):158–62. - PubMed
1. Van Acker K, Bouhassire D, De Bacquer D, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropatic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009;35:206–13. doi: 10.1016/j.diabet.2008.11.004. - DOI - PubMed
1. Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956–62. doi: 10.2337/diacare.28.4.956. - DOI - PubMed
1. Vallianou N, Evangelopoulos A, Koutalas P. Alpha-lipoic acid and diabetic neuropathy. Rev Diabet Stud. 2009;6(4):230–6. doi: 10.1900/RDS.2009.6.230. - DOI - PMC - PubMed
1. Daousi C, Benbow SJ, Woodward A, et al. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med. 2006;23:1021–4. doi: 10.1111/j.1464-5491.2006.01904.x. - DOI - PubMed

Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy - PubMed (original) (raw)